Abadenta - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,972,483 | 3,393,784 | 4,462,424 | 8,944,338 | 8,484,483 | 10,697,250 | 7,672,473 | 10,499,842 |
| Profit before tax | 9,710 | 22,608 | 37,298 | 42,173 | 57,568 | 251,069 | 199,814 | 115,905 |
| Net profit | 2,381 | 3,720 | 12,460 | 10,735 | 26,259 | 193,285 | 151,979 | 59,918 |
| Equity | 60,161 | 63,881 | 76,341 | 87,076 | 95,691 | 218,387 | 288,013 | 206,754 |
| Liabilities | 397,989 | 1,371,995 | 1,148,552 | 2,068,594 | 1,396,447 | 1,569,898 | 1,019,149 | 1,521,785 |
| Non-current assets | 351 | 10,601 | 11,145 | 12,589 | 9,280 | 7,195 | 4,198 | 3,033 |
| Current assets | 457,799 | 1,425,275 | 1,213,748 | 2,143,081 | 1,480,554 | 1,778,942 | 1,300,103 | 1,721,933 |
| Total assets | 458,150 | 1,435,876 | 1,224,893 | 2,155,670 | 1,489,834 | 1,786,137 | 1,304,301 | 1,724,966 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | - | 88,849 | 61,300 |
| Social insurance contributions | - | - | - | - | - | 59,316 | 100,514 | 128,673 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +17.7% | +72.1% | +31.5% | +100.4% | -5.1% | +26.1% | -28.3% | +36.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.5% | 0.3% | 1.0% | 0.5% | 1.8% | 10.8% | 11.7% | 3.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 4.0% | 5.8% | 16.3% | 12.3% | 27.4% | 88.5% | 52.8% | 29.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.1% | 0.1% | 0.3% | 0.1% | 0.3% | 1.8% | 2.0% | 0.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.5% | 0.7% | 0.8% | 0.5% | 0.7% | 2.3% | 2.6% | 1.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 6.6 | 21.5 | 15.0 | 23.8 | 14.6 | 7.2 | 3.5 | 7.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 223,301 | 380,610 | 505,182 | 675,044 | 669,826 | 713,150 | 442,644 | 529,405 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Abadenta - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-05-02 | 2023-05-08 | 6.47 |
| 2023-04-25 | 2023-04-28 | 6.47 |
| 2023-02-17 | 2023-02-21 | 3058.25 |
| 2022-09-16 | 2022-09-27 | 208.14 |
Abadenta - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-18 | 2026-03-18 | 4648.11 |
| 2026-02-14 | 2026-02-16 | 1848.53 |
| 2024-12-17 | 2024-12-17 | 6165.41 |
| 2024-11-17 | 2024-11-18 | 2637.85 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Abadenta, UAB (code 302421143) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €10.50M, up 36.9% year on year from €7.67M in 2024, and slightly below the €10.70M recorded in 2023. Net profit decreased to €59.9K in 2025 from €152.0K in 2024 and €193.3K in 2023, reducing the profit margin to 0.6% from 2.0% and 1.8% in the prior two years. The latest year therefore shows a recovery in turnover but weaker profitability. At the end of 2025, total assets stood at €1.72M, with equity of €206.8K and liabilities of €1.52M. Short-term assets accounted for almost all assets, while long-term assets were only €3.0K. The latest ratios indicate a high asset turnover of 6.09x, a debt-to-equity ratio of 7.36, and a low equity ratio of 12.0%. Revenue per employee was €552.6K, while profit per employee was €3.2K, pointing to strong sales generation but modest earnings per staff member.